Details for Patent: 11,602,522
✉ Email this page to a colleague
Which drugs does patent 11,602,522 protect, and when does it expire?
Patent 11,602,522 protects SOLOSEC and is included in one NDA.
This patent has sixteen patent family members in five countries.
Drugs Protected by US Patent 11,602,522
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Evofem Inc | SOLOSEC | secnidazole | GRANULE;ORAL | 209363-001 | Sep 15, 2017 | RX | Yes | Yes | 11,602,522 | ⤷ Subscribe | Y | TREATMENT OF TRICHOMONIASIS IN ADULTS | ⤷ Subscribe | |||
| Evofem Inc | SOLOSEC | secnidazole | GRANULE;ORAL | 209363-001 | Sep 15, 2017 | RX | Yes | Yes | 11,602,522 | ⤷ Subscribe | Y | TREATMENT OF TRICHOMONIASIS IN PATIENTS 12 YEARS OF AGE AND OLDER | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,602,522
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2015311674 | ⤷ Subscribe | |||
| Australia | 2018203882 | ⤷ Subscribe | |||
| Australia | 2018217262 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
